This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bentzon N, During M, Rasmussen BB, Mouridsen H, Kroman N: Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 2008; 122: 1089–1094.BentzonNDuringMRasmussenBBMouridsenHKromanN:Prognostic effect of estrogen receptor status across age in primary breast cancer.Int J Cancer2008;122:1089–1094.10.1002/ijc.22892Search in Google Scholar
Park SH, Knobf MT, Sutton KM: Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms. Clin J Oncol Nurs 2012; 16: 260–266.ParkSHKnobfMTSuttonKM:Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms.Clin J Oncol Nurs2012;16:260–266.10.1188/12.CJON.260-266Search in Google Scholar
Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J et al.: Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 2008; 111: 365–372.HenryNLGilesJTAngDMohanMDadabhoyDRobargeJ:Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Breast Cancer Res Treat2008;111:365–372.10.1007/s10549-007-9774-6Search in Google Scholar
Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D et al.: Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007; 25: 3877–3883.CrewKDGreenleeHCapodiceJRaptisGBrafmanLFuentesD:Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.J Clin Oncol2007;25:3877–3883.10.1200/JCO.2007.10.7573Search in Google Scholar
Zivian MT, Salgado B: Side Effects Revisited: Women’s Experiences with Aromatase Inhibitors. Breast Cancer Action, San Francisco 2008.ZivianMTSalgadoB:Side Effects Revisited: Women’s Experiences with Aromatase Inhibitors.Breast Cancer Action,San Francisco2008.Search in Google Scholar
Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al.: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005; 365: 60–62.HowellACuzickJBaumMBuzdarADowsettMForbesJF:Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer.Lancet2005;365:60–62.10.1016/S0140-6736(04)17666-6Search in Google Scholar
Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS et al.: Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer 2013; 119: 2375–2382.CastelLDHartmannKEMayerIASavilleBRAlvarezJBoomershineCS:Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.Cancer2013;119:2375–2382.10.1002/cncr.28016368700923575918Search in Google Scholar
Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW: Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 2012; 134: 459–478.MurphyCCBartholomewLKCarpentierMYBluethmannSMVernonSW:Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Breast Cancer Res Treat2012;134:459–478.10.1007/s10549-012-2114-5360728622689091Search in Google Scholar
Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26: 556–562.PartridgeAHLaFountainAMayerETaylorBSWinerEAsnis-AlibozekA:Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.J Clin Oncol2008;26:556–562.10.1200/JCO.2007.11.545118180462Search in Google Scholar
Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C: Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 2013; 108: 1515–1524.MakubateBDonnanPTDewarJAThompsonAMMcCowanC:Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.Br J Cancer2013;108:1515–1524.10.1038/bjc.2013.116362942723519057Search in Google Scholar
Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C: Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Res Treat 2010; 120: 127–134.BriotKTubiana-HulinMBastitLKloosIRouxC:Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study.Breast Cancer Res Treat2010;120:127–134.10.1007/s10549-009-0692-720035381Search in Google Scholar
Dizdar O, Ozcakar L, Malas FU, Harputluoglu H, Bulut N, Aksoy S et al.: Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 2009; 27: 4955–4960.DizdarOOzcakarLMalasFUHarputluogluHBulutNAksoyS:Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.J Clin Oncol2009;27:4955–4960.10.1200/JCO.2008.20.5435Search in Google Scholar
Morales L, Pans S, Paridaens R, Westhovens R, Timmerman D, Verhaeghe J et al.: Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 2007; 104: 87–91.MoralesLPansSParidaensRWesthovensRTimmermanDVerhaegheJ:Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging.Breast Cancer Res Treat2007;104:87–91.10.1007/s10549-006-9394-6Search in Google Scholar
Shanmugam VK, McCloskey J, Elston B, Allison SJ, Eng-Wong J: The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms. Breast Cancer Res Treat 2012; 131: 699–708.ShanmugamVKMcCloskeyJElstonBAllisonSJEng-WongJ:The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.Breast Cancer Res Treat2012;131:699–708.10.1007/s10549-011-1849-8Search in Google Scholar
Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C et al.: A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer 2010; 116: 4360–4367.HenryNLJacobsonJABanerjeeMHaydenJSmerageJBVan PoznakC:A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.Cancer2010;116:4360–4367.10.1002/cncr.25385Search in Google Scholar
Morales L, Pans S, Verschueren K, Van Calster B, Paridaens R, Westhovens R et al.: Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 2008; 26: 3147–3152.MoralesLPansSVerschuerenKVan CalsterBParidaensRWesthovensR:Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.J Clin Oncol2008;26:3147–3152.10.1200/JCO.2007.15.4005Search in Google Scholar
Singer O, Cigler T, Moore AB, Levine AB, Hentel K, Belfi L et al.: Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study. Arthritis Care Res (Hoboken) 2012; 64: 1910–1918.SingerOCiglerTMooreABLevineABHentelKBelfiL:Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.Arthritis Care Res (Hoboken)2012;64:1910–1918.10.1002/acr.21756Search in Google Scholar
Lintermans A, Laenen A, Van Calster B, Van Hoydonck M, Pans S, Verhaeghe J et al.: Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data. Ann Oncol 2013; 24: 350–355.LintermansALaenenAVan CalsterBVan HoydonckMPansSVerhaegheJ:Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data.Ann Oncol2013;24:350–355.10.1093/annonc/mds290Search in Google Scholar
Sarvazyan AP, Rudenko OV, Swanson SD, Fowlkes JB, Emelianov SY: Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics. Ultrasound Med Biol 1998; 24: 1419–1435.SarvazyanAPRudenkoOVSwansonSDFowlkesJBEmelianovSY:Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics.Ultrasound Med Biol1998;24:1419–1435.10.1016/S0301-5629(98)00110-0Search in Google Scholar
Taljanovic MS, Gimber LH, Becker GW, Latt LD, Klauser AS, Melville DM et al.: Shear-wave elastography: basic physics and musculoskeletal applications. Radiographics 2017; 37: 855–870.TaljanovicMSGimberLHBeckerGWLattLDKlauserASMelvilleDM:Shear-wave elastography: basic physics and musculoskeletal applications.Radiographics2017;37:855–870.10.1148/rg.2017160116545288728493799Search in Google Scholar
Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA et al.: Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 2019; 37: 423–438.BursteinHJLacchettiCAndersonHBuchholzTADavidsonNEGelmonKA:Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update.J Clin Oncol2019;37:423–438.10.1200/JCO.18.0116030452337Search in Google Scholar
Dirrichs T, Quack V, Gatz M, Tingart M, Kuhl CK, Schrading S: Shear wave elastography (SWE) for the evaluation of patients with tendinopathies. Acad Radiol 2016; 23: 1204–1213.DirrichsTQuackVGatzMTingartMKuhlCKSchradingS:Shear wave elastography (SWE) for the evaluation of patients with tendinopathies.Acad Radiol2016;23:1204–1213.10.1016/j.acra.2016.05.01227318786Search in Google Scholar
Ham S, Kim S, Choi H, Lee Y, Lee H: Greater muscle stiffness during contraction at menstruation as measured by shear-wave elastography. Tohoku J Exp Med 2020; 250: 207–213.HamSKimSChoiHLeeYLeeH:Greater muscle stiffness during contraction at menstruation as measured by shear-wave elastography.Tohoku J Exp Med2020;250:207–213.10.1620/tjem.250.20732238619Search in Google Scholar
Caprioli M, Carrara G, Sakellariou G, Silvagni E, Scire CA: Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology. RMD Open 2017; 3: e000523.CaprioliMCarraraGSakellariouGSilvagniEScireCA:Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology.RMD Open2017;3:000523.10.1136/rmdopen-2017-000523564008929071118Search in Google Scholar